What is the optimal duration of DAPT in patients treated with DES?
The optimal duration of DAPT therapy in patients treated with DES is not well established. However, aspirin is continued indefinitely in all patients managed with a bare-metal stent or DES, and DAPT is an option for >12 months in patients who have received a DES. This determination should balance the risks of stent thrombosis and ischemic complications versus bleeding and should be jointly made by the clinician and the patient.